High demand for at-home COVID-19 tests Could hamper supply, Abbott Says
Aug 30, 2021
Sales have skyrocketed due to the surge in cases driven by the highly transmissible delta variant
No BinaxNOW despite ‘red’ zone designation? Contact HHS, federal testing czar says
Oct 06, 2020
Eldercare facility operators who believe they are qualified but have not yet received shipments of BinaxNOW Ag Card tests for COVID-19 may email the agency at a dedicated address, Adm. Brett Giroir said...
Sterile option for glucose testing available
Mar 03, 2015
The FreeStyle Precision Pro system from Abbott allows providers to test blood glucose levels with individually-wrapped test strips, the company said.
Government, Abbott Laboratories reach $5.5M settlement over stents
Jan 07, 2014
The Department of Justice and Abbott Laboratories agreed to a $5.48 million settlement on Dec. 27 related to allegations that physicians received kickbacks for pushing stents.
Pfizer gets FDA approval for rheumatoid arthritis treatment
Nov 09, 2012
Federal regulators approved Pfizer’s new Xeljanz treatment for rheumatoid arthritis Tuesday. The potentially lucrative drug is now poised to enter a market that already features Humira, Abbott Laboratories’...
Abbott Labs to pay a huge price for promoting off-label use
May 09, 2012
Abbott Laboratories will pay $1.5 billion over allegations that it improperly promoted the anti-seizure drug Depakote for dementia care. The firm also reportedly paid kickbacks to physicians and long-term...
Researchers ‘stunned’ to find approved cholesterol drug has negligible effect
May 31, 2011
The National Institutes of Health announced it is ending its study of the cholesterol drug Niaspan 18 months early. Tracking results showed the medication had almost no chance of being beneficial to patients,...